We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.13B
AUM Growth
+$334M
Cap. Flow
-$281M
Cap. Flow %
-3.08%
Top 10 Hldgs %
21.52%
Holding
2,368
New
73
Increased
154
Reduced
1,152
Closed
75

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.6M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.94M
3
CZR icon
Caesars Entertainment
CZR
+$3.71M
4
IAA
IAA, Inc. Common Stock
IAA
+$3.57M
5
RUN icon
Sunrun
RUN
+$3.42M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$22.2M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$15.9M
3
MSFT icon
Microsoft
MSFT
+$13.6M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.6M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$9.15M

Sector Composition

Rank Sector Weight
1 Technology 22.17%
2 Healthcare 13.84%
3 Financials 12.41%
4 Consumer Discretionary 11.36%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNEX icon
1501
StoneX
SNEX
$8.05B
$392K ﹤0.01%
38,819
– –
VCRA
1502
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$390K ﹤0.01%
13,407
– –
PCVX icon
1503
Vaxcyte
PCVX
$8.76B
$388K ﹤0.01%
+7,862
New +$313K
ADVM
1504
DELISTED
Adverum Biotechnologies
ADVM
$387K ﹤0.01%
3,762
+501
+15% +$75K
ATRI
1505
DELISTED
Atrion Corp
ATRI
$387K ﹤0.01%
618
– –
ATRA icon
1506
Atara Biotherapeutics
ATRA
$76.7M
$386K ﹤0.01%
1,190
– –
EVH icon
1507
Evolent Health
EVH
$527M
$386K ﹤0.01%
31,066
– –
AKR icon
1508
Acadia Realty Trust
AKR
$2.86B
$383K ﹤0.01%
36,489
– –
KALU icon
1509
Kaiser Aluminum
KALU
$2.99B
$383K ﹤0.01%
7,148
– –
UPLD icon
1510
Upland Software
UPLD
$17.9M
$382K ﹤0.01%
1,014
– –
CALX icon
1511
Calix
CALX
$2.51B
$382K ﹤0.01%
21,486
– –
PRDO icon
1512
Perdoceo Education
PRDO
$1.99B
$381K ﹤0.01%
31,150
– –
AMRC icon
1513
Ameresco
AMRC
$1.47B
$381K ﹤0.01%
11,403
– –
ENTA icon
1514
Enanta Pharmaceuticals
ENTA
$391M
$380K ﹤0.01%
8,294
– –
CRS icon
1515
Carpenter Technology
CRS
$26.6B
$379K ﹤0.01%
20,845
-28,389
-58% -$614K
BEAM icon
1516
Beam Therapeutics
BEAM
$2.74B
$378K ﹤0.01%
15,372
+8,751
+132% +$217K
LNTH icon
1517
Lantheus
LNTH
$6.59B
$378K ﹤0.01%
29,842
– –
ATNX
1518
DELISTED
Athenex, Inc. Common Stock
ATNX
$377K ﹤0.01%
1,557
– –
TRHC
1519
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$377K ﹤0.01%
9,238
– –
DRH icon
1520
Diamondrock Hospitality Co
DRH
$2.51B
$375K ﹤0.01%
74,001
-15,684
-17% -$81.5K
SPNS
1521
DELISTED
Sapiens International
SPNS
$375K ﹤0.01%
12,263
– –
PRA
1522
DELISTED
ProAssurance
PRA
$375K ﹤0.01%
23,948
– –
CVA
1523
DELISTED
Covanta Holding Corporation
CVA
$375K ﹤0.01%
48,325
-9,013
-16% -$82.7K
ALEX
1524
DELISTED
Alexander & Baldwin
ALEX
$374K ﹤0.01%
33,353
– –
BUSE icon
1525
First Busey Corp
BUSE
$2.58B
$374K ﹤0.01%
23,513
– –
59 60
61
62 63

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, MetLife Investment Management held 2,368 positions worth $9.13B, up 3.8% from $8.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

MetLife Investment Management withdrew a net $281M in Q3 2020, closing 75 positions and reducing 1,152 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $7.44M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Jazz Pharmaceuticals worth $4.53M.

  • MetLife Investment Management's largest Q3 2020 buy was Jazz Pharmaceuticals: 31,753 shares worth $4.53M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $34.6M increase.
  • MetLife Investment Management's biggest Q3 2020 reduction was Apple, cutting an estimated $22.2M.
  • MetLife Investment Management fully exited Slack Technologies, Inc. in Q3 2020, selling an estimated $7.44M.
  • MetLife Investment Management's ten largest holdings make up 22% of its $9.13B portfolio in Q3 2020.
  • MetLife Investment Management opened 73 new positions and closed 75 in Q3 2020.
  • MetLife Investment Management's portfolio value rose 3.8% quarter-over-quarter to $9.13B.

Based on MetLife Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.